Our results may provide a mechanistic basis for the recent observation that anti-PD-1 mAb promotes flu, simian immunodeficiency virus), or tumor vaccine responses (Herati et al., 2022; Liu et al., 2022; Rahman et al., 2021) and increases circulating Tfh cells (Herati et al., 2022). This evidence concerns the gene RPL17 and neoplasm.